|1.||Sonomoto, Kenji: 1 article (02/2013)|
|2.||Tsumori, Hideaki: 1 article (02/2013)|
|3.||Sakurai, Yutaka: 1 article (02/2013)|
|4.||Shimizu, Yoshitaka: 1 article (02/2013)|
|5.||Yamakami, Kazuo: 1 article (02/2013)|
|6.||Nagatoshi, Kohei: 1 article (02/2013)|
|7.||Casey, Pat G: 1 article (01/2013)|
|8.||Field, Des: 1 article (01/2013)|
|9.||Ross, R Paul: 1 article (01/2013)|
|10.||Campion, Alicia: 1 article (01/2013)|
|1.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/01/2012 - "Nisin, a bacteriocin and commonly used food preservative, may serve as a novel potential therapeutic for treating head and neck squamous cell carcinoma (HNSCC), as it induces preferential apoptosis, cell cycle arrest, and reduces cell proliferation in HNSCC cells, compared with primary keratinocytes. "
01/01/2013 - "This analysis revealed that nisin V was more effective than Nisin A with respect to controlling infection and therefore merits further investigation with a view to potential chemotherapeutic applications."
01/01/2013 - "Here we address this issue by assessing the ability of nisin A and nisin V to control a bioluminescent strain of Listeria monocytogenes EGDe in a murine infection model.More"
08/01/2010 - "Statistically significant increases of water consumption, urine volume, and urinary sodium and chlorine, and decreases of urinary potassium and serum sodium, along with increases of absolute and relative kidney weight, and incidences of minimal squamous cell hyperplasia of limiting ridge in the forestomach, were found in nisin A-treated groups. "